Floatz logo

QUETIAPINE

Mood Disorder

First Affiliated Hospital of Zhejiang UniversitySmall moleculePhase 4 / ApprovedActive
BBB
76/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
63/ 100
Competitive Position
95/ 100

Competitive context

10 Active assets in the Mood Disorder cohort.

Asset / SponsorPhaseRating
Brexpiprazole
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 3BBB
Olanzapine
University of Ghana Medical School
Phase 4BBB
Minocycline
Pakistan Institute of Living and Learning
Phase 4BBB
FLUOXETINE
University of Ghana Medical School
Phase 4BBB
Paliperidone Palmitate 3-Month Formulation
Luye Pharma Group Ltd.
Phase 3BB

View all 33 →

Same molecule, other indications

QUETIAPINE is also rated in:

substance abuseDormant
BBB
Indicative ·
78 / 100
View asset →
schizoaffective disorderDormant
BBB
Indicative ·
77 / 100
View asset →
psychotic disorderDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →